An insurance company decided that profits matter more than the life of a man who spent his career protecting this city,” said ...
5don MSN
City asked to intervene after SF firefighter's stage 4 lung cancer treatment denied by Blue Shield
For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
IMAGES BELOW] 11-month sustained complete resolution of lung metastasis observed in Bria-OTS Phase 1/2a metastatic breast ...
InvestorsHub on MSN
ImmunityBio shares jump after Saudi approval of ANKTIVA for lung cancer
Shares of ImmunityBio (NASDAQ:IBRX) climbed 6% on Wednesday morning after the company said Saudi Arabia’s Food and Drug ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
More Americans diagnosed with cancer are now surviving the disease - marking a positive trend that experts say reflects the ...
Less than two weeks into the new year, the American Cancer Society released its annual report on what to expect in 2026 when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback